ubmslatePT-logo-ubm

PT Mobile Logo

Topics:

Schizophrenia

A Stunning Discovery

A paradigm-shifting finding holds the potential to alter how we perceive brain-immune interactions.

Related content:
Genetics of Psychotic Disorders

©Lassedesignen/Shutterstock

Schizophrenia

We are in the midst of a paradigm shift in the field, and new diagnostics and treatments that yield clinically significant improvement for the heterogeneous set of disorders known as schizophrenia are being developed.

The need to stay up-to-date with the most current evidence-based information is becoming harder than ever. For this reason, the authors identify and evaluate published research that may have a direct bearing on clinical practice.

Aggressive and impulsive behaviors in schizophrenia pose many clinical challenges. The best way to reduce the risk of aggression is with adequate treatment of schizophrenia.

©Lassedesignen/Shutterstock

A paradigm-shifting finding holds the potential to alter how we perceive brain-immune interactions for disorders like schizophrenia and Alzheimer disease. It would enable a more mechanistic approach to the study of the neuroimmunology of these and other disorders.

Treatment with a selective estrogen receptor modulator in adjunct to antipsychotics was associated with improvements in attention and memory in men and women with schizophrenia in a recent trial.

A recent study from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) investigated the genetics of the auditory event-related potential, a putative psychosis biomarker.

An analysis of symptom severity across domains may enable us to reevaluate how we categorize symptoms within the spectrum of psychotic illness.

Pages

Subscribe to Schizophrenia on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.